About: Cancer Surgery Scheduling During and After the COVID-19 First Wave: The MD Anderson Cancer Center Experience

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Cancer Surgery Scheduling During and After the COVID-19 First Wave: The MD Anderson Cancer Center Experience Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Cancer Surgery Scheduling During and After the COVID-19 First Wave: The MD Anderson Cancer Center Experience
Creator	Katz, Matthew Davis, John Shafer, Aaron Adelman, David Aloia, Thomas Antonoff, Mara Bird, Justin Cao, Hop Caudle, Abigail Desnyder, Sarah Lai, Stephen Mehran, Reza Moon, Bryan Prabhu, Sujit Reece, Gregory Roland, Christina Schmeler, Kathleen Skibber, John Swisher, Stephen Teshome, Mediget Tzeng, Ching-Wei Vauthey, Jean-Nicolas Weinberg, Jeffrey
Source	Medline; PMC
abstract	OBJECTIVE: To summarize the multi-specialty strategy and initial guidelines of a Case Review Committee in triaging oncologic surgery procedures in a large Comprehensive Cancer Center and to outline current steps moving forward after the initial wave. SUMMARY OF BACKGROUND DATA: The impetus for strategic rescheduling of operations is multifactorial and includes our societal responsibility to minimize COVID-19 exposure risk and propagation among patients, the healthcare workforce, and our community at large. Strategic rescheduling is also driven by the need to preserve limited resources. As many states have already or are considering to re-open and relax stay-at-home orders, there remains a continued need for careful surgical scheduling because we must face the reality that we will need to co-exist with COVID-19 for months, if not years. METHODS: The quality officers, chairs, and leadership of the 9 surgical departments in our Division of Surgery provide specialty-specific approaches to appropriately triage patients. RESULTS: We present the strategic approach for surgical rescheduling during and immediately after the COVID-19 first wave for the 9 departments in the Division of Surgery at The University of Texas MD Anderson Cancer Center in Houston, Texas. CONCLUSIONS: Cancer surgeons should continue to use their oncologic knowledge to determine the window of opportunity for each surgical procedure, based on tumor biology, preoperative treatment sequencing, and response to systemic therapy, to safely guide patients through this cautious recovery phase.
has issue date	2020-05-18(xsd:dateTime)
bibo:doi	10.1097/sla.0000000000004092
bibo:pmid	32675511
has license	no-cc
sha1sum (hex)	6517cfa5dfe972d691583ecbb6fbbc6b0bd84954
schema:url	https://doi.org/10.1097/sla.0000000000004092
resource representing a document's title	Cancer Surgery Scheduling During and After the COVID-19 First Wave: The MD Anderson Cancer Center Experience
has PubMed Central identifier	PMC7373457
has PubMed identifier	32675511
schema:publication	Ann Surg
resource representing a document's body	covid:6517cfa5dfe972d691583ecbb6fbbc6b0bd84954#body_text
is schema:about of	named entity 'provide' named entity 'departments' named entity 'Cancer' named entity 'COVID-19' named entity 'Surgery' named entity 'OPPORTUNITY' named entity 'TREATMENT' named entity 'SURGICAL' named entity 'YEARS' named entity 'RESULTS' named entity 'PRESERVE' named entity 'WORKFORCE' named entity 'SURGEONS' named entity 'surgical procedure' named entity 'determine' named entity 'limited resources' named entity 'rescheduling' named entity 'multifactorial' named entity 'COVID-19' named entity 'rescheduling' named entity 'Comprehensive Cancer Center' named entity 'systemic therapy' named entity 'Cancer Surgery' named entity 'COVID-19' named entity 'radiotherapy' named entity 'PPE' named entity 'malignant' named entity 'mastectomy' named entity 'COVID-19' named entity 'endometrial cancer' named entity 'ICU' named entity 'severe pain' named entity 'neoadjuvant chemotherapy' named entity 'PPE' named entity 'patient safety' named entity 'gray areas' named entity 'tumors' named entity 'surgical procedures' named entity 'hypopharynx' named entity 'histologies' named entity 'oncology' named entity 'cancer treatment' named entity 'COVID-19' named entity 'midline shift' named entity 'metastatic disease' named entity 'immunosuppressed' named entity 'transfusion' named entity 'computed tomography' named entity 'Autologous' named entity 'multi-disciplinary' named entity 'COVID-19' named entity 'intubation' named entity 'chemotherapy' named entity 'tumors' named entity 'malignant' named entity 'stage II' named entity 'virus' named entity 'sarcomas' named entity 'stereotactic radiation therapy'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software